AstraZeneca rises after report on U.S. listing plans

6 days ago 2

• Healthcare

Roland Magnusson/iStock Editorial via Getty Images

AstraZeneca (NASDAQ:AZN) ADRs added ~2% in the morning hours on Tuesday after The Times reported that CEO Sir Pascal Soriot has privately indicated his willingness to shift the company’s stock listing to the U.S. from the U.K.

Citing people familiar

Recommended For You

More Trending News

See More »

1. Homepage
2. Politics
3. AstraZeneca rises after report on U.S. listing plans